<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Phys Ther Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Phys Ther Sci</journal-id><journal-id journal-id-type="publisher-id">JPTS</journal-id><journal-title-group><journal-title>Journal of Physical Therapy Science</journal-title></journal-title-group><issn pub-type="ppub">0915-5287</issn><issn pub-type="epub">2187-5626</issn><publisher><publisher-name>The Society of Physical Therapy Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26311975</article-id><article-id pub-id-type="pmc">4540873</article-id><article-id pub-id-type="publisher-id">jpts-2015-190</article-id><article-id pub-id-type="doi">10.1589/jpts.27.2327</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effects of a 12-hour neuromuscular electrical stimulation treatment program
on the recovery of upper extremity function in sub-acute stroke patients: a randomized
controlled pilot trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cui</surname><given-names>Bao-Juan</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Dao-Qing</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Qiu</surname><given-names>Jian-Qing</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Lai-Gang</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Fan-Shuo</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Qi</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Min</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Ben-Ling</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Qiang-San</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><aff id="aff1"><label>1)</label> Department of Rehabilitation, The Second Hospital of
Shandong University, Shandong Univeristy, China</aff><aff id="aff2"><label>2)</label> Department of Obstetrics and Gynecology, The Second
Hospital of Shandong University, Shandong Univeristy, China</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Qiang-San Sun, Department of Rehabilitation, The Second Hospital of
Shandong University, Shandong Univeristy: 247 Beiyuan street, Jinan 250033, China. (E-mail: <email xlink:href="sunqsan@126.com">sunqsan@126.com</email>; <email xlink:href="randomdarkbluetea@163.com">randomdarkbluetea@163.com</email>; <email xlink:href="m13592675735@163.com">m13592675735@163.com</email>)</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>7</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2015</year></pub-date><volume>27</volume><issue>7</issue><fpage>2327</fpage><lpage>2331</lpage><history><date date-type="received"><day>09</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>16</day><month>4</month><year>2015</year></date></history><permissions><copyright-statement>2015&#x000a9;by the Society of Physical Therapy Science. Published by IPEC
Inc.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>[Purpose] This study investigated the effects of a 12-hour neuromuscular electrical
stimulation program in the evening hours on upper extremity function in sub-acute stroke
patients. [Subjects and Methods] Forty-five subjects were randomized to one of three
groups: 12-hour neuromuscular electrical stimulation group (n=15), which received 12 hours
of neuromuscular electrical stimulation and conventional rehabilitation for the affected
upper extremity; neuromuscular electrical stimulation group (n=15), which received 30&#x02005;min
of neuromuscular electrical stimulation and conventional rehabilitation; and control group
(n=15), which received conventional rehabilitation only. The Fugl-Meyer assessment, Action
Research Arm Test, and modified Ashworth scale were used to evaluate the effects before
and after intervention, and 4 weeks later. [Results] The improvement in the distal
(wrist-hand) components of the Fugl-Meyer assessment and Action Research Arm Test in the
12-hour neuromuscular electrical stimulation group was more significant than that in the
neuromuscular electrical stimulation group. No significant difference was found between
the two groups in the proximal component (shoulder-elbow) of the Fugl-Meyer assessment.
[Conclusion] The 12-hour neuromuscular electrical stimulation group achieved better
improvement in upper extremity motor function, especially in the wrist-hand function. This
alternative therapeutic approach is easily applicable and can be used in stroke patients
during rest or sleep.</p></abstract><kwd-group><title>Key words</title><kwd>Neuromuscular electrical stimulation</kwd><kwd>Upper extremity function</kwd><kwd>Stroke</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Upper extremity (UE) hemiparesis is a frequently encountered post-stroke impairment<xref rid="r1" ref-type="bibr">1</xref><sup>)</sup>; most of the UE functional recovery is
thought to occur within the initial 6 months after the stroke, and the extent of recovery is
very limited<xref rid="r2" ref-type="bibr">2</xref><sup>)</sup>. UE disability has a great
impact on the activities of daily living and imparts a heavy burden on survivors&#x02019; families
and society<xref rid="r3" ref-type="bibr">3</xref><sup>)</sup>.</p><p>Neuromuscular electrical stimulation (NMES) has long been used in post-stroke
rehabilitation<xref rid="r4" ref-type="bibr">4</xref><sup>)</sup>. Many studies have
reported the effects of NMES in the prevention of muscle atrophy, decrease of spasticity,
increase of muscle strength, and facilitation of functional movement recovery<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>.
However, performing NMES in daily practice is challenging because of the differences in the
stimulation characteristics: technique, frequency, intensity, and duration<xref rid="r8" ref-type="bibr">8</xref><sup>)</sup>. The best choice for rehabilitation of the
paretic upper extremity is still unclear. Past studies have shown that totally a minimum of
10 hours of NMES in combination with regular rehabilitation may improve the recovery of arm
function in stroke patients during the acute stage<xref rid="r9" ref-type="bibr">9</xref><sup>)</sup>. The implication was that the cumulative effect of treatment time
might be a key player in NMES therapy. However, in standard clinical settings, increasing
the stimulation time beyond 1 hour during the day is not practically feasible<xref rid="r9" ref-type="bibr">9</xref><sup>)</sup>.</p><p>Treatment involving 12 hours of NMES (12h-NMES) maybe a new alternative therapeutic
approach in which the treatment is assigned in the evening when subjects wear a portable
device while remaining at rest or during sleep. The intensity of the electrical current is
adjusted to produce a small contraction of the target muscle without inducing obvious
limb/joint movement, with the subject in a comfortable state and undistracted by the
stimulation<xref rid="r10" ref-type="bibr">10</xref><sup>)</sup>.</p><p>A randomized, controlled, observer-blinded pilot trial was conducted to compare the
improvement in motor control and muscle tone in sub-acute stroke patients who participated
in a 12h-NMES, NMES, or conventional rehabilitation program. The purpose of this trial was
to evaluate the effects of long-duration (12 hours in the evening), low-intensity NMES on
upper extremity function in stroke patients.</p></sec><sec sec-type="methods" id="s2"><title>SUBJECTS AND METHODS</title><p>A total of 132 patients who had developed hemiplegia as a result of stroke were recruited
from the Second Hospital of Shandong University from July 2012 to May 2014. The inclusion
and exclusion criteria are listed in <xref rid="tbl_001" ref-type="table">Table
1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Inclusion and exclusion criteria</title></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="top" rowspan="5" colspan="1">Inclusion criteria</td><td align="left" valign="top" rowspan="1" colspan="1">Age, 18&#x02013;80 years</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Time from stroke onset&#x02265;4 weeks </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">First stroke and unilateral involvement </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Medically and neurologically stable condition</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No visual or auditory defects</td></tr><tr><td colspan="2" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="6" colspan="1">Exclusion criteria</td><td align="left" valign="top" rowspan="1" colspan="1">Recurrent or progressive stroke</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pre-existing arm impairment such as rheumatoid
arthritis</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cardiac pacemaker or other implanted stimulator</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">History of seizures within 2 years</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">History of fatal cardiac arrhythmias</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Refusal to sign the consent form</td></tr></tbody></table></table-wrap>. Eighty-seven patients who did not fulfill the inclusion criteria were
excluded. The remaining 45 patients were enrolled and randomized to one of three groups, (1)
12h-NMES group, (2) NMES group, or (3) control group, via a computer-generated blocked
randomization sequence. Approval was received from the ethics committees of the study site,
and written informed consent was obtained from each participant in accordance with the
ethical standards of the Declaration of Helsinki.</p><p>Eligible subjects, regardless of their group assignment, underwent standard inpatient
rehabilitation that included physical therapy, occupational therapy, activities of daily
living training, mobility training, and speech therapy. Additionally, the patients in
the12h-NMES and NMES groups received electric stimulation treatment for a 12-h or 30-min
session/day, respectively, 6 days/week, for 4 weeks. A portable surface neuromuscular
stimulator (Chattanooga-2773AS) was used to deliver the NMES. Rectangular-wave pulsed
currents (300 &#x003bc;s pulse width; 40&#x02005;Hz; 1&#x02005;s on/off ramp) were applied to the affected upper
extremities of the subjects in both NMES groups. The amplitude of the current in the NMES
group was adjusted to obtain the maximum range of wrist and finger extension without
discomfort, and in the 12h-NMES group, the intensity was adjusted to produce a small muscle
contraction without obvious limb/joint movement, with the patient in a comfortable state and
undistracted by the stimulation. The surface electrodes(5&#x000d7;5&#x02005;cm; square) were applied over
the motor points near the middle of the supraspinatus, the biceps brachii and the deltoid
muscle on the paretic side, as well as over the wrist extensors. The NMES treatment was
applied for 12 hours in the evening in the 12h-NMES group and for 30&#x02005;min during the day in
the NMES group.</p><p>Outcome measures included the upper extremity component of the Fugl-Meyer assessment
(FMA-UE), the Action Research Arm Test (ARAT), and the modified Ashworth scale (MAS). The
FMA-UE scores were divided into proximal (FMA-p, shoulder-elbow score, 0&#x02013;42) and distal
components (FMA-d, wrist-hand score, 0&#x02013;24). The ARAT consists of 19 items divided into four
subscales (grasp, grip, pinch, and gross movement) with a maximum score of 57 points. The
muscle tone of the biceps brachii and wrist flexors was assessed by the MAS, which uses a
6-point scale to assess the mean resistance to passive movement of the elbow and wrist. The
three measures were assessed at baseline, after four weeks of treatment, and at the
four-week follow-up by the physical therapists, who were blinded to the group assignment. A
flow chart of the study is shown in <xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Flow-chart of the randomization procedure. NMES: neuromuscular electrical
stimulation</p></caption><graphic xlink:href="jpts-27-2327-g001"/></fig>.</p><p>All statistical analyses were performed with SPSS version 15.0 (IBM Corp., Armonk, NY,
USA). Using one-way ANOVA and &#x003c7;<sup>2</sup> test, we compared the patients&#x02019; baseline
characteristics. The post-intervention and follow-up improvements in the groups were
compared using an independent-samples t-test. One-way ANOVA was used to compare outcome
measurements in each group, and p values&#x0003c;0.05 were considered statistically
significant.</p></sec><sec sec-type="results" id="s3"><title>RESULTS</title><p>Forty subjects completed the treatment and follow-up process. No adverse treatment effects,
such as burns, skin allergic responses, increased muscle tone, or obvious muscle fatigue
were noted. The patients in this study showed good adherence; only one patient in
the12h-NMES group denied treatment due to affected sleep quality. Four patients were lost to
follow-up because of transportation difficulties and inconvenience. No significant
differences were found in the baseline characteristics of the groups (<xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Baseline characteristics of patients included in the study
(n=45)<sup>a</sup></title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="middle" align="center" rowspan="1" colspan="1">12h-NMES group<break/>n=15</th><th valign="middle" align="center" rowspan="1" colspan="1">NMES group<break/>n=15</th><th valign="middle" align="center" rowspan="1" colspan="1">Control group<break/>n=15</th><th valign="middle" align="center" rowspan="1" colspan="1">p value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="top" rowspan="1" colspan="1">61.5&#x000b1;14.8</td><td align="center" valign="top" rowspan="1" colspan="1">64.6&#x000b1;7.5</td><td align="center" valign="top" rowspan="1" colspan="1">61.5&#x000b1;12.6</td><td align="center" valign="top" rowspan="1" colspan="1">0.72<sup>b</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender (male)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">0.12<sup>c</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Time since onset of stroke (weeks) </td><td align="center" valign="top" rowspan="1" colspan="1">12.6&#x000b1;6.1</td><td align="center" valign="top" rowspan="1" colspan="1">12.8&#x000b1;5.1</td><td align="center" valign="top" rowspan="1" colspan="1">14.4&#x000b1;4.9</td><td align="center" valign="top" rowspan="1" colspan="1">0.61<sup>b</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Affected side (left)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">0.31<sup>c</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Type of stroke </td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Infarction</td><td align="center" valign="top" rowspan="1" colspan="1">13 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (15)</td><td align="center" rowspan="1" colspan="1">0.86<sup>c</sup></td></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">hemorrhage</td><td align="center" valign="top" rowspan="1" colspan="1">2 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (15)</td><td align="center" rowspan="1" colspan="1">0.89<sup>c</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FMA</td><td align="center" valign="top" rowspan="1" colspan="1">17.1&#x000b1;4.59</td><td align="center" valign="top" rowspan="1" colspan="1">17.5&#x000b1;4.56</td><td align="center" valign="top" rowspan="1" colspan="1">17.1&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">0.96<sup>b</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ARAT</td><td align="center" valign="top" rowspan="1" colspan="1">16.1&#x000b1;5.58</td><td align="center" valign="top" rowspan="1" colspan="1">16.9&#x000b1;2.71</td><td align="center" valign="top" rowspan="1" colspan="1">17.3&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">0.52<sup>b</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MAS (elbow)</td><td align="center" rowspan="1" colspan="1">1.4&#x000b1;0.91</td><td align="center" rowspan="1" colspan="1">1.5&#x000b1;0.92</td><td align="center" rowspan="1" colspan="1">1.5&#x000b1;0.92</td><td align="center" rowspan="1" colspan="1">0. 90<sup>b</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MAS (wrist)</td><td align="center" rowspan="1" colspan="1">1.4&#x000b1;0.83</td><td align="center" rowspan="1" colspan="1">1.7&#x000b1;0.89</td><td align="center" rowspan="1" colspan="1">1.5&#x000b1;0.92</td><td align="center" rowspan="1" colspan="1">0.59<sup>b</sup></td></tr></tbody></table><table-wrap-foot><p>NMES: Neuromuscular electrical stimulation; FMA: Fugl-Meyer assessment; ARAT: Action
Research Arm Test; MAS: Modified Ashworth scale. <sup>a</sup> Values are mean &#x000b1; SD or
number (percentage). <sup>b</sup> One-way-ANOVA test</p><p><sup>c</sup> &#x003c7;<sup>2</sup> test</p></table-wrap-foot></table-wrap>).</p><p>Significant improvements in the FMA-d were found in the 12h-NMES group compared with the
NMES group at week 4 and at follow-up (T=2.89, p=0.007; T=3.01, p=0.003, respectively), and
improvements were also found in the control group (T=4.59, p=0.000; T=2.18, p=0.04,
respectively). Significant improvements in the FMA-p were obtained in the 12h-NMES group
compared with the control group at week 4 and at follow-up (T=2.78, p=0.01; T=4.55, p=0.000,
respectively), but no significant improvement was found in the NMES group between week 4 and
the follow-up (T=1.18, p=0.25; T=0.63, p=0.54, respectively). There was no difference
between the two NMES groups (T=1.41, p=0.17; T=1.20, p=0.43, respectively). Both NMES groups
showed significant improvements on the ARAT at week 4 and at follow-up. Furthermore, the
difference on the ARAT between the two NMES groups was significant (<xref rid="tbl_003" ref-type="table">Table 3</xref><table-wrap id="tbl_003" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Changes in clinical assessments among the three groups</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="middle" align="center" rowspan="1" colspan="1">12h-NMES group</th><th valign="middle" align="center" rowspan="1" colspan="1">NMES group</th><th valign="middle" align="center" rowspan="1" colspan="1">Control group</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">FMA-p</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">12.1&#x000b1;3.01</td><td align="center" rowspan="1" colspan="1">12.1&#x000b1;2.85</td><td align="center" rowspan="1" colspan="1">11.8&#x000b1;2.96</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 4</td><td align="center" rowspan="1" colspan="1">24.3&#x000b1;3.71<sup>**&#x000b6;</sup></td><td align="center" rowspan="1" colspan="1">22.1&#x000b1;4.65<sup>**</sup></td><td align="center" rowspan="1" colspan="1">20.1&#x000b1;4.29<sup>**</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 8</td><td align="center" rowspan="1" colspan="1">24.8&#x000b1;3.33<sup>**&#x000a7;</sup></td><td align="center" rowspan="1" colspan="1">23.7&#x000b1;4.55<sup>**</sup></td><td align="center" rowspan="1" colspan="1">22.7&#x000b1;3.50<sup>**</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FMA-d</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">5.07&#x000b1;1.94</td><td align="center" rowspan="1" colspan="1">5.40&#x000b1;1.72</td><td align="center" rowspan="1" colspan="1">5.33&#x000b1;1.76</td></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Week 4</td><td align="center" rowspan="1" colspan="1">13.7&#x000b1;3.25<sup>**&#x000a7;</sup></td><td align="center" rowspan="1" colspan="1">10.7&#x000b1;2.38<sup>**</sup></td><td align="center" rowspan="1" colspan="1">9.0&#x000b1;2.24<sup>**</sup></td></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Week 8</td><td align="center" rowspan="1" colspan="1">18.8&#x000b1;3.07<sup>**&#x000b6;</sup></td><td align="center" rowspan="1" colspan="1">15.4&#x000b1;3.53<sup>**</sup></td><td align="center" rowspan="1" colspan="1">14.29&#x000b1;2.90<sup>**</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ARAT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">16.1&#x000b1;3.575</td><td align="center" rowspan="1" colspan="1">16.9&#x000b1;2.71</td><td align="center" rowspan="1" colspan="1">17.3&#x000b1;2.85</td></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Week 4</td><td align="center" rowspan="1" colspan="1"> 26.6&#x000b1;3.28<sup>**&#x000a7;</sup></td><td align="center" rowspan="1" colspan="1"> 22.8&#x000b1;3.14<sup>**</sup></td><td align="center" rowspan="1" colspan="1"> 21.6&#x000b1;2.47<sup>**</sup></td></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Week 8</td><td align="center" rowspan="1" colspan="1"> 30.8&#x000b1;2.14<sup>**&#x000a7;</sup></td><td align="center" rowspan="1" colspan="1"> 26.9&#x000b1;2.85<sup>**</sup></td><td align="center" rowspan="1" colspan="1"> 24.6&#x000b1;2.98<sup>**</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MAS elbow</td><td align="left" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">1.40&#x000b1;0.91</td><td align="center" valign="top" rowspan="1" colspan="1">1.53&#x000b1;0.92</td><td align="center" rowspan="1" colspan="1">1.53&#x000b1;0.92</td></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Week 4</td><td align="left" rowspan="1" colspan="1">1.50&#x000b1;0.52</td><td align="center" valign="top" rowspan="1" colspan="1">1.67&#x000b1;0.49</td><td align="center" rowspan="1" colspan="1">1.80&#x000b1;0.68</td></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Week 8</td><td align="center" rowspan="1" colspan="1">1.67&#x000b1;0.65</td><td align="center" valign="top" rowspan="1" colspan="1">1.69&#x000b1;0.48</td><td align="center" rowspan="1" colspan="1">1.71&#x000b1;0.47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MAS wrist</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">1.40&#x000b1;0.83</td><td align="center" rowspan="1" colspan="1">1.73&#x000b1;0.88</td><td align="center" rowspan="1" colspan="1">1.53&#x000b1;0.91</td></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Week 4</td><td align="center" rowspan="1" colspan="1">1.36&#x000b1;0.63</td><td align="center" rowspan="1" colspan="1">1.67&#x000b1;0.49</td><td align="center" rowspan="1" colspan="1">1.53&#x000b1;0.52</td></tr><tr><td align="left" valign="top" style="padding-left:10pt" rowspan="1" colspan="1">Week 8</td><td align="center" rowspan="1" colspan="1">1.33&#x000b1;0.49</td><td align="center" rowspan="1" colspan="1">1.66&#x000b1;0.49</td><td align="center" rowspan="1" colspan="1">1.57&#x000b1;0.51</td></tr></tbody></table><table-wrap-foot><p>NMES: Neuromuscular electrical stimulation; FMA: Fugl-Meyer assessment; FMA-d:
Fugl-Meyer assessment distal component (wrist-hand); FMA-p: Fugl-Meyer assessment
proximal component (shoulder-elbow); ARAT: Action Research Arm Test; MAS: Modified
Ashworth scale. Comparison within group with independent-samples t-test: *p&#x0003c;0.05,
**p&#x0003c;0.001. Comparison among groups with one-way ANOVA: &#x000b6;p&#x0003c;0.05, &#x000a7;p&#x0003c;0.001</p></table-wrap-foot></table-wrap>).</p><p>No significant difference was found on the MAS for the elbow and wrist flexors among the
three groups at week 4 and at follow-up. There was no evidence of exacerbation or
alleviation of spasticity among the subjects, who showed mild to moderate elbow and wrist
spasticity (MAS 1&#x02013;2) (<xref rid="tbl_003" ref-type="table">Table 3</xref>). </p></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>The present study evaluated the effectiveness of rehabilitation using 12h-NMES in the
evening hours in sub-acute stroke patients. Compared with the NMES group, the 12h-NMES group
experienced the following effects: (1) better improvement of motor function in the affected
UE, especially in the wrist-hand function; and (2) limited improvement in spasticity. Our
findings support the effectiveness of the 12h-NMES therapy, which maybe an alternative
therapeutic approach for patients at rest or during sleep.</p><p>A 12h-NMES program can facilitate motor function recovery in the affected UE after stroke,
especially in the distal UE. At present, brain plasticity is the most widely accepted
functional theory of recovery after stroke. The adult animal brain has been proven to
demonstrate plasticity, including nerve sprouting and synaptic activation, under repetitive
stimulation<xref rid="r11" ref-type="bibr">11</xref><sup>)</sup>. The mechanism underlying
12h-NMES-driven changes in motor function remains unclear but is thought to be the
activation of brain plasticity through electrical enhancement of the afferent input<xref rid="r12" ref-type="bibr">12</xref><sup>)</sup>. Dose-dependent use is known to induce
reorganization of the damaged motor cortex<xref rid="r13" ref-type="bibr">13</xref><sup>)</sup>. The 12h-NMES treatment and constraint-induced movement therapy are
supposed to induce dose-dependent plasticity<xref rid="r14" ref-type="bibr">14</xref><sup>)</sup>. The 12h-NMES treatment allowed patients to receive stimulation for
12hours in the evening, with sustained electrical afferent input and without affected sleep
quality. The 12h-NMES treatment had the advantage of long-duration stimulation over the NMES
treatment, which maintained stimulation for only 30&#x02005;min per day. In this study, the 12h-NMES
group showed significant improvements on the FMA and the ARAT and achieved greater
improvement on the FMA-d than the FMA-p. Several factors may account for the relatively
small changes in FMA-p. Generally, most sub-acute and chronic stroke patients have better
proximal UE motor function than distal, mainly due to more effective training of the
proximal UE than the distal UE in the early stages of stroke recovery, and the FMA-p scores
tend to change more easily in acute than sub-acute or chronic stroke patients. As mentioned
above, in the present study, most of the subjects were sub-acute stroke patients. Therefore,
the small significant improvements in FMA-p are not surprising. Additionally, the low
intensity of the electrical current and limited stimulus field (with a large variation
between the muscle volumes in the proximal and distal parts of the UE) dedicated to the
proximal portion of the UE muscles possibly limited the magnitude of improvement. The
significant difference on the ARAT between the two NMES groups also indicated that the
12h-NMES group improved more in the distal UE because most of the items (16/19) on the ARAT
assessment are related to distal function (finger tasks). In line with our results, a recent
study also observed that additional NMES applications during treatment could bring about
more improvement in distal motor functions and found difference in the muscle activities
between the wrist and the elbow; improved distal muscle coordination led to better motor
functional recovery<xref rid="r15" ref-type="bibr">15</xref><sup>)</sup>.To verify and
extend these findings, future investigations of this study&#x02019;s treatment method should focus
on determining the type of stimulation that might be most effective, the optimum dose, and
the optimum application time after stroke.</p><p>The 12h-NMES treatment showed limited effects on spasticity. The MAS is important for
assessing the degree of spasticity that develops as a result of upper motor neuron lesions.
However, the results of the NMES studies performed to evaluate spasticity are controversial.
Although some studies have shown that NMES relieved spasticity<xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r17" ref-type="bibr">17</xref><sup>)</sup>, others have
suggested that NMES had a limited effect on spasticity<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r15" ref-type="bibr">15</xref>, <xref rid="r18" ref-type="bibr">18</xref><sup>)</sup>. These differences may be due to sample size, intervention time,
treatment therapy, and outcome measures. In this present study, there was no evidence of
exacerbation or alleviation of spasticity among the subjects who showed mild to moderate
spasticity in their elbow and wrist muscles during the treatment and follow-up sessions.</p><p>This study demonstrated that four weeks of 12h-NMES can improve motor control of the
paretic UE in sub-acute stroke patients. The stimulation protocol (long-duration,
low-intensity) seemed to provide greater improvement in the distal UE than in the proximal
UE. The positive effects observed in this study suggest that further development of this
long-duration, low-intensity NMES is warranted. An important advantage of the 12h-NMES
treatment is that it is not restricted by time, equipment, or space. Furthermore, the device
used is easily portable due to its size, and after receiving instructions, patients are
easily able to apply the device themselves or with the help of family members.</p><p>Our study had several limitations. One limitation was the sample size, which was small
because the study was designed to perform an initial assessment of the 12h-NMES treatment
program. Other weaknesses included the mixture of stroke types and levels of impairment at
the sub-acute stages of stroke. Further studies using a similar stimulation treatment
program with a larger sample size are needed to verify the effectiveness of the 12h-NMES and
gain further insight into the mechanism of the intervention.</p></sec></body><back><ack><p>This paper was supported by the Natural Science Foundation of Shandong Province (grant
no.ZR2014HL080) and The Second Hospital of Shandong University (grant no. 2013010008).</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Boyaci</surname><given-names>A</given-names></name><name><surname>Topuz</surname><given-names>O</given-names></name><name><surname>Alkan</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>: <article-title>Comparison of the effectiveness of active and passive
neuromuscular electrical stimulation of hemiplegic upper extremities: a randomized,
controlled trial</article-title>. <source>Int J Rehabil Res</source>, <year>2013</year>,
<volume>36</volume>: <fpage>315</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="pmid">23579106</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Duncan</surname><given-names>PW</given-names></name><name><surname>Lai</surname><given-names>SM</given-names></name><name><surname>Keighley</surname><given-names>J</given-names></name></person-group>: <article-title>Defining post-stroke recovery: implications for design and
interpretation of drug trials</article-title>. <source>Neuropharmacology</source>,
<year>2000</year>, <volume>39</volume>: <fpage>835</fpage>&#x02013;<lpage>841</lpage>.
<pub-id pub-id-type="pmid">10699448</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Aoyagi</surname><given-names>Y</given-names></name><name><surname>Tsubahara</surname><given-names>A</given-names></name></person-group>: <article-title>Therapeutic orthosis and electrical stimulation for upper
extremity hemiplegia after stroke: a review of effectiveness based on
evidence</article-title>. <source>Top Stroke Rehabil</source>, <year>2004</year>,
<volume>11</volume>: <fpage>9</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="pmid">15480949</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Malhotra</surname><given-names>S</given-names></name><name><surname>Rosewilliam</surname><given-names>S</given-names></name><name><surname>Hermens</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>: <article-title>A randomized controlled trial of surface neuromuscular
electrical stimulation applied early after acute stroke: effects on wrist pain,
spasticity and contractures</article-title>. <source>Clin Rehabil</source>,
<year>2013</year>, <volume>27</volume>: <fpage>579</fpage>&#x02013;<lpage>590</lpage>.
<pub-id pub-id-type="pmid">23129814</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>LK</given-names></name><name><surname>Lee</surname><given-names>JU</given-names></name><etal>et al.</etal></person-group>: <article-title>A pilot study on the effect of functional electrical
stimulation of stroke patients in a sitting position on balance and activities of daily
living</article-title>. <source>J Phys Ther Sci</source>, <year>2013</year>,
<volume>25</volume>: <fpage>1097</fpage>&#x02013;<lpage>1101</lpage>. <pub-id pub-id-type="pmid">24259923</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>MY</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>JU</given-names></name><etal>et al.</etal></person-group>: <article-title>The effects of functional electrical stimulation on
balance of stroke patients in the standing posture</article-title>. <source>J Phys Ther
Sci</source>, <year>2012</year>, <volume>24</volume>:
<fpage>77</fpage>&#x02013;<lpage>81</lpage>. </mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Levine</surname><given-names>M</given-names></name><name><surname>McElroy</surname><given-names>K</given-names></name><name><surname>Stakich</surname><given-names>V</given-names></name><etal>et al.</etal></person-group>: <article-title>Comparing conventional physical therapy rehabilitation
with neuromuscular electrical stimulation after TKA</article-title>.
<source>Orthopedics</source>, <year>2013</year>, <volume>36</volume>:
<fpage>e319</fpage>&#x02013;<lpage>e324</lpage>. <pub-id pub-id-type="pmid">23464951</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>de Kroon</surname><given-names>JR</given-names></name><name><surname>Ijzerman</surname><given-names>MJ</given-names></name><name><surname>Chae</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>: <article-title>Relation between stimulation characteristics and clinical
outcome in studies using electrical stimulation to improve motor control of the upper
extremity in stroke</article-title>. <source>J Rehabil Med</source>, <year>2005</year>,
<volume>37</volume>: <fpage>65</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="pmid">15788340</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Hsu</surname><given-names>SS</given-names></name><name><surname>Hu</surname><given-names>MH</given-names></name><name><surname>Wang</surname><given-names>YH</given-names></name><etal>et al.</etal></person-group>: <article-title>Dose-response relation between neuromuscular electrical
stimulation and upper-extremity function in patients with stroke</article-title>.
<source>Stroke</source>, <year>2010</year>, <volume>41</volume>:
<fpage>821</fpage>&#x02013;<lpage>824</lpage>. <pub-id pub-id-type="pmid">20203321</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Shimodozono</surname><given-names>M</given-names></name><name><surname>Noma</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>: <article-title>Repetitive facilitative exercise under continuous
electrical stimulation for severe arm impairment after sub-acute stroke: a randomized
controlled pilot study</article-title>. <source>Brain Inj</source>, <year>2014</year>,
<volume>28</volume>: <fpage>203</fpage>&#x02013;<lpage>210</lpage>. <pub-id pub-id-type="pmid">24304090</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Peurala</surname><given-names>SH</given-names></name><name><surname>Pitk&#x000e4;nen</surname><given-names>K</given-names></name><name><surname>Sivenius</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>: <article-title>Cutaneous electrical stimulation may enhance sensorimotor
recovery in chronic stroke</article-title>. <source>Clin Rehabil</source>,
<year>2002</year>, <volume>16</volume>: <fpage>709</fpage>&#x02013;<lpage>716</lpage>.
<pub-id pub-id-type="pmid">12428819</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Schuhfried</surname><given-names>O</given-names></name><name><surname>Crevenna</surname><given-names>R</given-names></name><name><surname>Fialka-Moser</surname><given-names>V</given-names></name><etal>et al.</etal></person-group>: <article-title>Non-invasive neuromuscular electrical stimulation in
patients with central nervous system lesions: an educational review</article-title>.
<source>J Rehabil Med</source>, <year>2012</year>, <volume>44</volume>:
<fpage>99</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="pmid">22334346</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Nudo</surname><given-names>RJ</given-names></name><name><surname>Milliken</surname><given-names>GW</given-names></name></person-group>: <article-title>Reorganization of movement representations in primary
motor cortex following focal ischemic infarcts in adult squirrel
monkeys</article-title>. <source>J Neurophysiol</source>, <year>1996</year>,
<volume>75</volume>: <fpage>2144</fpage>&#x02013;<lpage>2149</lpage>. <pub-id pub-id-type="pmid">8734610</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Wolf</surname><given-names>SL</given-names></name><name><surname>Winstein</surname><given-names>CJ</given-names></name><name><surname>Miller</surname><given-names>JP</given-names></name><etal>et al.</etal></person-group>: <article-title>Retention of upper limb function in stroke survivors who
have received constraint-induced movement therapy: the EXCITE randomised
trial</article-title>. <source>Lancet Neurol</source>, <year>2008</year>,
<volume>7</volume>: <fpage>33</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="pmid">18077218</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Hu</surname><given-names>XL</given-names></name><name><surname>Tong</surname><given-names>RK</given-names></name><name><surname>Ho</surname><given-names>NS</given-names></name><etal>et al.</etal></person-group>: <article-title>Wrist rehabilitation assisted by an
electromyography-driven neuromuscular electrical stimulation robot after
stroke</article-title>. <source>Neurorehabil Neural Repair</source>, <year>2014</year>.
</mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Yan</surname><given-names>T</given-names></name></person-group>: <article-title>Long-term effectiveness of neuromuscular electrical
stimulation for promoting motor recovery of the upper extremity after
stroke</article-title>. <source>J Rehabil Med</source>, <year>2011</year>,
<volume>43</volume>: <fpage>506</fpage>&#x02013;<lpage>510</lpage>. <pub-id pub-id-type="pmid">21533330</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Sahin</surname><given-names>N</given-names></name><name><surname>Ugurlu</surname><given-names>H</given-names></name><name><surname>Albayrak</surname><given-names>I</given-names></name></person-group>: <article-title>The efficacy of electrical stimulation in reducing the
post-stroke spasticity: a randomized controlled study</article-title>. <source>Disabil
Rehabil</source>, <year>2012</year>, <volume>34</volume>:
<fpage>151</fpage>&#x02013;<lpage>156</lpage>. <pub-id pub-id-type="pmid">21999668</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Noma</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name><name><surname>Shimodozono</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>Novel neuromuscular electrical stimulation system for the
upper limbs in chronic stroke patients: a feasibility study</article-title>. <source>Am
J Phys Med Rehabil</source>, <year>2014</year>, <volume>93</volume>:
<fpage>503</fpage>&#x02013;<lpage>510</lpage>. <pub-id pub-id-type="pmid">24508928</pub-id></mixed-citation></ref></ref-list></back></article>